Three-month, randomized, parallel-group comparison of brimonidine–timolol versus dorzolamide–timolol fixed-combination therapy*

Author: Nixon Donald R.   Yan David B.   Chartrand Jean-Pierre   Piemontesi Roberto L.   Simonyi Susan   Hollander David A.  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.25, Iss.7, 2009-07, pp. : 1645-1653

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content